Khristine Ghemigian BA, Presenter: Nothing to Disclose

Stefan Puchner MD, Abstract Co-Author: Nothing to Disclose

Pal Maurovich-Horvat MD, Abstract Co-Author: Nothing to Disclose

Udo Hoffmann MD, Abstract Co-Author: Nothing to Disclose

Maros Ferencik MD, Abstract Co-Author: Nothing to Disclose

Michael Tse-Yin Lu MD, Abstract Co-Author: Nothing to Disclose

The goals of this exhibit are to: 1. Teach how to evaluate high risk coronary plaque features on CCTA with correlation to ex vivo histology 2. Review evidence for high risk plaque features as predictors of future cardiac events

A. Beyond stenosis: CCTA’s unique role as the only noninvasive imaging test to assess high risk plaque features B. CCTA high risk plaque features with correlation to ex vivo histology C. How to identify high risk plaque features on CCTA 1. Low attenuation 2. Positive remodeling 3. Spotty calcium 4. Napkin ring sign D. High risk plaque features for the prediction of major adverse cardiac events: Literature review and experience from ROMICAT II

http://abstract.rsna.org/uploads/2014/14006547/14006547_9khq.pdf

Ghemigian, K, Puchner, S, Maurovich-Horvat, P, Hoffmann, U, Ferencik, M, Lu, M, How to Identify High Risk Coronary Plaque on CCTA: Experience from ROMICAT-II.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14006547.html